# Calyseed

> Calyseed is a VC fund in Lentilly backing Biotechnology and Pharmaceutical. See 3 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Lentilly, France
- Total investments: 3
- Last investment: Jun 2025
- Lead investor: 67%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/calyseed/

Calyseed is a seed fund specializing in the healthcare sector.

## Contacts

5 contacts available for Calyseed. Shizune tracks 1 team members at Calyseed. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/calyseed?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 67% |
| Pharmaceutical | 2 | 67% |
| Medical | 1 | 33% |
| Biopharma | 1 | 33% |
| 3D Printing | 1 | 33% |

8 industries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Elodie Panier | Co-founder and General Director | 1 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Oria Bioscience | Oria Bioscience is a pure biotechnology company that produces intact organelles for therapeutic opportunities. | $3.1M | Seed | Jun 19, 2025 |  |
| MSInsight | MSInsight bioinformatics start-up that develops diagnostic and treatment response prediction solutions for Microsatellite Instability (MSI) cancers. Its service offering focuses on diagnostic and prognostic biomarkers of treatment response for MSI tumors. | $1.7M | Seed | Mar 10, 2025 |  |
| MB Therapeutics | MB Therapeutics is a pharmaceutical firm that provides patient-centric solutions for developing and producing tailored medicines. | $2.1M | Seed | Feb 24, 2025 |  |

3 of 3 investments shown.

## Co-investors
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund, 2 deals together
- [Angels Santé](https://shizune.co/investors/profile/angels-sant) — VC Fund, 1 deal together
- BEPREP — VC Fund, 1 deal together
- [Capital Cell](https://shizune.co/investors/profile/capital-cell) — VC Fund, 1 deal together
- [Cenitz](https://shizune.co/investors/profile/cenitz) — VC Fund, 1 deal together
- [Galion.exe](https://shizune.co/investors/profile/galion-exe) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Calyseed invest in?

Calyseed invests primarily in Biotechnology, Pharmaceutical and Medical startups, most often at Seed stage. Most of the 3 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Calyseed?

Public channels for Calyseed include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Calyseed?

The team at Calyseed includes Elodie Panier (Co-founder and General Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co